https://www.selleckchem.com/HSP-90.html
A service model was established for pregnant women with positive screening results for hepatitis B surface antigen (HBsAg) at Queen Mary Hospital in Hong Kong. All women were offered a blood test for hepatitis B virus (HBV) DNA level during the first antenatal visit. Women with HBV DNA levels of ≥200 000 IU/mL received counselling from hepatologists regarding treatment with antenatal tenofovir disoproxil fumarate (TDF) 300 mg daily. This retrospective review included women attending our antenatal clinic who exhibited positive HBsAg screening resu
Mi piace
Commento
Condividi
